Mosuolit (Nimesulide)

Nimesulide is an NSAID that reduces inflammation and pain by inhibiting cyclooxygenase‑2.

• Pain relief: alleviates mild to moderate musculoskeletal, postoperative or dental pain.
• Fever reduction: lowers elevated body temperature in acute febrile states.
• Osteoarthritis: decreases joint inflammation and improves mobility in degenerative joint disease.
• Dysmenorrhea: relieves menstrual cramps associated with primary dysmenorrhea.

• Nimesulide selectively inhibits the cyclooxygenase‑2 (COX‑2) enzyme, which blocks the conversion of arachidonic acid to prostaglandins. The resulting decrease in prostaglandin synthesis reduces inflammation, nociceptive signaling, and the hypothalamic set‑point for temperature, providing analgesic, antipyretic, and anti‑inflammatory effects.

Nimesulide may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain.
• Headache: mild to moderate intensity.
• Skin rash: transient erythematous eruptions.
• Dizziness: occasional vertiginous sensations.
• Elevated liver enzymes: mild, transient increases.

Serious or Rare Side Effects

• Hepatotoxicity: severe liver injury or failure.
• Severe cutaneous reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Gastrointestinal ulceration or bleeding.
• Renal impairment: acute kidney injury.
• Anaphylaxis: life‑threatening hypersensitivity reaction.
• Blood dyscrasias: agranulocytosis or aplastic anemia.

Before prescribing Mosuolit, clinicians should consider several safety measures.

• Assess liver function: monitor hepatic enzymes before and during therapy.
• Evaluate hypersensitivity: avoid in patients with known allergy to nimesulide or other NSAIDs.
• Renal caution: adjust use in patients with impaired kidney function.
• Elderly risk: limit duration due to increased gastrointestinal and renal adverse events.
• Concomitant COX‑2 inhibitors or high‑dose aspirin: avoid to reduce bleeding risk.
• Store at ambient temperature: keep in the original pack, protect from moisture and light.

Nimesulide can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• Other NSAIDs or COX‑2 inhibitors: heightened risk of gastrointestinal bleeding.
• Anticoagulants (e.g., warfarin, heparin): increased bleeding tendency.
• Hepatotoxic agents (e.g., high‑dose paracetamol, isoniazid): potential liver injury.
• Lithium: concurrent use may raise serum lithium levels.

Moderate Interactions (Monitor Closely)

• Corticosteroids: additive ulcerogenic effect.
• Diuretics or ACE inhibitors: possible reduction in renal perfusion.
• Methotrexate: may increase methotrexate toxicity.